• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Tales from the History of Psychiatry: Opium, an Ancient Psychotropic

Tales from the History of Psychiatry: Opium, an Ancient Psychotropic

September 1, 2016
Marcia Zuckerman, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Marcia Zuckerman, MD Director of psychiatric services at Walden Behavioral Care in Waltham, MA Dr. Zuckerman has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
These days, opiates are primarily prescribed to treat pain. But there is a long history of using opiates to treat depression and other mental illness. Starting in the 700s, Arabian cultures used opium in mental hospitals in Baghdad, Damascus, Fez, and Cairo that also incorporated milieu therapy such as music, reading, and sexual stimulation. In the Victorian era, Thomas Sydenham popularized Sydenham’s Laudanum, a mixture of opium, sherry, wine, and herbs. Laudanum, which was affordable at 20 or 25 drops for a penny, was used for depression and hysteria, as well as to soothe small children. (The laudanum that is currently available by prescription in the U.S., often known as “tincture of opium,” no longer contains alcohol.) Many of the opium preparations were prescribed for women in response to problems with menstruation and childbirth, as well as “the vapours,” a loose term that included hysteria, depression, mood swings, and fainting. As physicians began to appreciate the risk of addiction with opium preparations, they fell out of favor in the medical establishment, leading to regulation and, essentially, prohibition, in 1914 by the Harrison Narcotics Tax Act. Interestingly, the use of opiates to treat depression may have come full circle. Small research studies (eg, Bodkin JA et al, J Clin Psychopharmacol 1995;15(1):49–57) have shown a benefit for Suboxone, an opiate partial agonist-antagonist in treatment resistant depression, although the risk of addiction and misuse may outweigh the benefits.
General Psychiatry
KEYWORDS addiction substance-abuse
Marcia Zuckerman, MD

More from this author
www.thecarlatreport.com
Issue Date: September 1, 2016
SUBSCRIBE NOW
Table Of Contents
Treating Complicated Grief: Grief-Focused Psychotherapy Is More Effective Than Citalopram
Take The CME Post-Test for Pain Management, TCPR, September 2016
Managing Pain: A Cognitive Behavioral Therapist’s Approach
Evaluating and Treating Pain in Psychiatric Patients
Tales from the History of Psychiatry: Opium, an Ancient Psychotropic
DOWNLOAD NOW
Featured Book
  • MFB6eCover.jpg

    Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

    Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto4921771.jpg
    General Psychiatry

    Psychopharm Commandment #6: MAOIs

    MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.